Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness

Medical Hypotheses

Volumn 50, Issue 6, 1998, Pages 511-514

  McCarty, M F ^a  

^a Nutrition 21 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4 (3 PYRIDYL) 4H NAPHTHO[1,2 B]PYRAN 3 CARBONITRILE; FISH OIL; HEPARIN; POLYPHENOL; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CANCER; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; TEA; TRANSACTIVATION; TUMOR VASCULARIZATION;

ANIMALIA;

EID: 0031802510     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90273-0     Document Type: Article

References (47)

1. Yoshioka K, Deng T, Cavigelli M, Karin M. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc Natl Acad Sci USA 1995; 92: 4972-4976.
2. Suzuki T, Okuno H, Yoshida T et al. Difference in transcriptional regulatory function between c-fos and fra-2. Nucleic Acids Res 1991; 19: 5537-5542.
3. Prestera T, Holtzclaw W D, Zhang Y, Talalay P. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA 1993; 90: 2965-2969.
4. Jaiswal A K. Commentary. Antioxidant response element. Biochem Pharmacol 1994; 48: 439-444.
5. Nguyen T, Rushmore T H, Pickett C B. Transcriptional regulation of a rat liver glutathione S-transferase Ya subunit gene. J Biol Chem 1994; 269: 13656-13662.
6. Angel P, Karin M. The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-157.
7. Devary Y, Gottlieb R A, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992; 71: 1081-1091.
8. Lloyd A, Yancheva N, Wasylyk B. Transformation suppressor activity of a jun transcription factor lacking its activation domain. Nature 1991; 352: 635-638.
9. Angel P, Baumann I, Stein B et al. 10-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 1987; 7: 2256-2266.
10. Gutman A, Wasylyk B. The collagenase gene promoter contains a TPA and oncogene-responsiveness unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990; 9: 2241-2246.
11. Mackay A R, Ballin M, Pelina M D et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cells lines. Invasion Metastasis 1992; 12: 168-184.
12. Auble D T, Brinckerhoff C E. The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 1991; 30: 4629-4635.
13. Crawford H C, Matrisian L M. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996; 49: 20-37.
14. Nerlov C, Rorth P, Blasi F, Johnsen M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell-type specific activity. Oncogene 1991; 6: 1583-1592.
15. Nerlov C, De Casare D, Pergola F et al. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol-ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J 1992; 11: 4573-4582.
16. Montesano R, Orci L. Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 1985; 42: 469-477.
17. Morris P B, Hida T, Blackshear P J et al. Tumor-promoting phorbol esters induce angiogenesis in vivo. Am J Physiol 1988; 254: C318-C322.
18. Tsopanoglou N E, Pipili-Synetos E, Maragoudakis M E. Protein kinase C involvement in the regulation of angiogenesis. J Vasc Res 1993; 30: 202-208.
19. Takahashi S, Sato T, Ito A et al. Involvement of protein kinase C in the interleukin 1α-induced gene expression of matrix metalloproteinases and tissue inhibitor-1 of metalloproteinases (TIMP-1) in human uterine cervical fibroblasts. Biochim Biophys Acta 1993;1220: 57-65.
20. Hu D E, Fan T-PD. Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat. Inflammation 1995; 19: 39-54.
21. Schonthal A, Herrlich P, Rahmsdorf H, Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988; 35: 325-334.
22. Moses M A, Sudhalter J, Langer R. Isolation and characterization of an inhibitor of neoyascularization from scapular chondrocytes. J Cell Biol 1992; 119: 475-482.
23. Pepper M S, Vassalli J-D, Montesano R, Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987; 105: 2535-2541.
24. Avery R L, Connor T B Jr, Farazdaghi M. Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophthalmol 1990; 108: 1474-1476.
25. DeClerck Y A, Laug W E. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression. Enzyme Protein 1996; 49: 72-84.
26. MacDougall J R, Matrisian L M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev 1996; 14: 351-367.
27. Gopalakrishna R, Barsky S H. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc Natl Acad Sci USA 1988; 85: 612-616.
28. Bonfil R D, Momiki S, Fridman R et al. Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-O-tetra-decanoyl-phorbol-13-acetate and diacylglycerol. Carcinogenesis 1989; 10: 2335-2338.
29. Takenaga K, Takahashi K. Effects of 12-O-tetradecanoyl-phorbol-13-acetate on adhesiveness and lung-colonizing ability of Lewis lung carcinoma cells. Cancer Res 1986; 46: 375-380.
30. Stoner G D, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem 1995; suppl. 22: 169-180.
31. Oguni I, Nasu K, Yamamoto S, Nomura T. On the antitumor activity of fresh green tea leaf. Agric Biol Chem 1988; 52: 1879-1880.
32. Wang Z Y, Huang M-T, Ho C-T et al. Inhibitory effect of green tea on the growth of established skin papillomas in mice. Cancer Res 1992; 52: 6657-6665.
33. Taniguchi S, Fujiki H, Kobayashi H et al. Effect of (-)epigallo-catechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 1992; 65: 51-54.
34. Sazuka M, Murakami S, Isemura M et al. Inhibitory effects of green tea infusion on in vitro invasion and in vivo metastasis of mouse lung carcinoma cells. Cancer Lett 1995; 98: 27-31.
35. Khan S G, Katiyar S K, Agarwal R, Mukhtar H. Enhancement of anti-oxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemo-prevention. Cancer Res 1992; 52: 4050-4052.
36. Agarwal R, Katiyar S K, Zaidi S I A, Mukhtar H. Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res 1992; 52: 3582-3588.
37. Peña A, Wu S, Hickok N J et al. Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-myc/max protein complex. J Cell Physiol 1995; 162: 234-245.
38. McCarty M F. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med Hypotheses 1996; 46: 107-115.
39. Wong S-H, Marsh J B. Inhibition of apolipoprotein secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat liver. Metabolism 1988; 37: 1177-1181.
40. Surette M E, Whelan J, Broughton K S, Kinsella J E. Evidence for mechanisms of the hypotriglyceridemic effect of n-3 poly-unsaturated fatty acids. Biochim Biophys Acta 1992; 1126: 199-205.
41. Pukac L A, Castellot J J Jr, Wright T C Jr et al. Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regulation 1990; 1: 435-443.
42. Pukac L A, Ottlinger M E, Karnovsky M J. Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 1992; 267: 3707-3711.
43. Folkman V. How is blood vessel growth regulated in normal and neoplastic tissue? - G.H.A. Clowes Memorial Award lecture. Cancer Res 1986; 46: 467-473.
44. Birch K A, Heath W F, Hermeling R N et al. LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response element. Diabetes 1996; 45: 642-650.
45. Kwaan H C. The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev 1992; 11: 291-311.
46. Ishii H, Jirousek M R, Koya D et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 1996; 272: 728-731.
47. McCarty M F. Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion - the 'PKC syndrome'. Med Hypotheses 1996; 46: 191-221.